In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

COVID-19 vaccination in early pregnancy (≤20 weeks of gestation) is not associated with increased prevalence of major ...

4/BA.5 and original strains of SARS-CoV-2, compared to mRNA-1273.222, Moderna’s previously approved bivalent Omicron BA.4/BA.5-targeting COVID vaccine. Per management, the benefit was primarily ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Independent reviewers confirmed a causal relationship between the first mRNA COVID-19 vaccines and myocarditis, and also ...

The booster shot – called mRNA-1273.211 – offered better and longer-lasting protection compared to the original SpikeVax shot against all SARS-CoV-2 variants, including the prevailing Omicron ...

1. Characterization of lipid components in lipid nanoparticle (LNP) formulations – Application Note AN001928 – ...

mRNA-1345 plus bivalent COVID-19 mRNA-1273.214, or mRNA-1273.214 plus placebo. In both parts, patients received vaccines and placebo via intramuscular injection into the deltoid muscle ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.